Hopkins study props up PARP inhibitors for Parkinson's

A study in mice showed the potential of repurposed PARP-1 inhibitors to reverse aggregate α-synuclein-induced neuronal cell death in Parkinson's disease.

PARP inhibitors Lynparza olaparib, Zejula

Read the full 254 word article

User Sign In